Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Covington
Mallinckrodt
Teva
Daiichi Sankyo
Citi

Generated: September 15, 2019

DrugPatentWatch Database Preview

Belatacept - Biologic Drug Details

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for belatacept
Tradenames:1
Patents:17
Applicants:1
BLAs:1
Suppliers: see list1

US Patents for belatacept

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Bristol Myers Squibb NULOJIX belatacept INJECTABLE; INJECTION 125288 001 2011-06-15 ➤ Sign Up Excision BioTherapeutics, Inc. (Bedminster, unknown) Temple University of the Commonwealth System of Higher Education (Philadelphia, unknown) 2039-05-17 RX search
Bristol Myers Squibb NULOJIX belatacept INJECTABLE; INJECTION 125288 001 2011-06-15 ➤ Sign Up Icahn School of Medicine at Mount Sinai (New York, NY) 2034-06-26 RX search
Bristol Myers Squibb NULOJIX belatacept INJECTABLE; INJECTION 125288 001 2011-06-15 ➤ Sign Up ChemoCentryx, Inc. (Mountain View, CA) 2036-04-04 RX search
Bristol Myers Squibb NULOJIX belatacept INJECTABLE; INJECTION 125288 001 2011-06-15 ➤ Sign Up Perle Bioscience, Inc. (Atlanta, GA) 2032-09-27 RX search
Bristol Myers Squibb NULOJIX belatacept INJECTABLE; INJECTION 125288 001 2011-06-15 ➤ Sign Up Bristol-Myers Squibb Company (Princeton, NJ) Domantis Limited (Brentford, Middlesex, GB) 2031-10-13 RX search
Bristol Myers Squibb NULOJIX belatacept INJECTABLE; INJECTION 125288 001 2011-06-15 ➤ Sign Up Momenta Pharmaceuticals, Inc. (Cambridge, MA) 2036-04-30 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for belatacept

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
11/036 Ireland ➤ Sign Up PRODUCT NAME: BELATACEPT; REGISTRATION NO/DATE: EU/1/11/694/001-002 20110617
00509 Netherlands ➤ Sign Up PRODUCT NAME: BELATACEPT; REGISTRATION NO/DATE: EU/1/11/694/001 - 002 20110617
C/GB11/061 United Kingdom ➤ Sign Up PRODUCT NAME: BELATACEPT; REGISTERED: UK EU/1/11/694/001 20110617; UK EU/1/11/694/002 20110617
2011100063 Germany ➤ Sign Up PRODUCT NAME: BELATACEPT; REGISTRATION NO/DATE: EU/1/11/694/001-002 20110617
C0053 France ➤ Sign Up PRODUCT NAME: BELATACEPT; REGISTRATION NO/DATE: EU/1/11/694/001-002 20110617
2011014 Lithuania ➤ Sign Up PRODUCT NAME: BELATACEPTUM; REGISTRATION NO/DATE: EU/1/11/694/001, 2011 06 17 EU/1/11/694/002 20110617
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Baxter
Queensland Health
Argus Health
US Army
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.